{"id":119499,"date":"2025-02-19T01:58:00","date_gmt":"2025-02-19T07:58:00","guid":{"rendered":"https:\/\/www.unmc.edu\/newsroom\/?p=119499"},"modified":"2025-09-30T14:29:37","modified_gmt":"2025-09-30T19:29:37","slug":"dr-mahapatra-grant-to-fund-medulloblastoma-research","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/","title":{"rendered":"Dr. Mahapatra grant to fund medulloblastoma research\u00a0"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p>A new grant will help cancer researchers explore how to lessen toxicity in drugs that are used to fight brain cancer in children.<\/p>\n\n\n\n<p>The Child Health Research Institute announced the new National Cancer Institute research grant awarded to a team led by Sidharth Mahapatra, MD, PhD, associate professor, UNMC Departments of Pediatrics and Biochemistry and Molecular Biology, and critical care physician with Children\u2019s Nebraska.<\/p>\n\n\n\n<p>Awarded as part of the NCI Small Grants Program for Cancer Research, the two-year R03 grant will advance Dr. Mahapatra\u2019s research on Group 3 medulloblastoma (G3MB), the most lethal form of medulloblastoma.\u00a0<\/p>\n\n\n\n<p>Dr. Mahapatra said G3MBs are the most aggressive form of medulloblastoma, with survival rates of less than 50% after five years.<\/p>\n\n\n\n<p>\u201cThe challenge with current treatment strategies lies in their overall toxicity to growing children,\u201d said Dr. Mahapatra, chair of the Nebraska Children\u2019s Brain Tumor Collaborative and co-chair of the Brain Tumor Working Group at the Fred &amp; Pamela Buffett Cancer Center. \u201cChemotherapy drugs often have to be given in lower doses to minimize side effects in children, which can lead to cancer returning even more aggressively.\u201d<\/p>\n\n\n\n<p>This new funding will allow Dr. Mahapatra and his team to explore treating G3MB with a novel strategy that targets B7-H3 signaling.<\/p>\n\n\n\n<p>B7-H3 is part of a family of B7 proteins that are expressed at levels that normally regulate the immune system, Dr. Mahapatra said. However, in G3MB, these molecules are expressed at much higher levels and allow tumors to hide from the immune system and grow unchecked, he said.<\/p>\n\n\n\n<p>Dr. Mahapatra&#8217;s previous research showed that blocking B7-H3 slows down the growth and spread of G3MB cancer cells in lab experiments.<\/p>\n\n\n\n<p>Dr. Mahapatra acknowledges that aggressive cancers in adults already are being treated with therapies targeting B7-H3. However, these treatments, like antibody-based drugs or CAR T-cell therapy, are expensive, can precipitate serious side effects or have difficulty crossing into the brain. Small-molecule inhibitors of B7-H3 may provide several tangible advantages.<\/p>\n\n\n\n<p>\u201cFirst, their small size and solubility allow ready penetration into the brain. Second, their manufacturing cost is low, and storage conditions are less stringent than antibody- or CAR-based therapies,\u201d Dr. Mahapatra said. \u201cA library of inhibitors can be generated and efficiently screened to identify the best therapeutic compounds based on safety profiles, tissue and tumor penetration, half-life in the body and oral bioavailability.\u201d<\/p>\n\n\n\n<p>The goal of this research is to prove that targeting B7-H3 is an effective and safe way to treat G3MB. If successful, the team hopes to combine these new lead compounds with existing treatments to create therapies that remain toxic to cancer cells but are easier on young patients.<\/p>\n\n\n\n<p>\u201cThe ultimate goal is to develop a therapeutic approach that mitigates current toxicities while maintaining a high index of anti-cancer effect,\u201d Dr. Mahapatra said. \u201cThis could lead to better survival rates and improved quality of life for children and their families who are suffering from this devastating disease.\u201d<\/p>\n\n\n\n<p>Dr. Mahapatra is collaborating with Paul Trippier, PhD, associate professor at the UNMC College of Pharmacy. Dr. Trippier\u2019s research focuses on small-molecule drug discovery for cancer and neurodegenerative diseases. His lab employs synthetic, medicinal chemistry, chemical biology and molecular pharmacology techniques to design, optimize and employ biologically active compounds for probing human disease pathways and to be lead compounds for novel drug discovery.<\/p>\n\n\n\n<p>\u201cHis team was instrumental in identifying the first small-molecule drug that targets B7-H3, which will be a key part of this project,\u201d Dr. Mahapatra said.<\/p>\n\n\n\n<p>Joann Sweasy, PhD, director of the Fred &amp; Pamela Buffett Cancer Center and the Eppley Institute for Research in Cancer and Allied Diseases, said, \u201cDr. Mahapatra&#8217;s work in testing a novel therapeutic target for Group 3 medulloblastoma has the potential to transform how we treat this aggressive cancer, especially in children, bringing us closer to safer and more effective therapies.\u201d<\/p>\n\n\n\n<p>\u201cWe are proud to support and be part of such critical research at the Fred &amp; Pamela Buffett Cancer Center,\u201d Dr. Sweasy said.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>The team led by Sidharth Mahapatra, MD, PhD is exploring a novel treatment against the most lethal form of medulloblastoma.\u00a0<\/p>\n","protected":false},"author":75,"featured_media":119500,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"67444,67966,58220,116381,64343,40172","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[3606],"class_list":["post-119499","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-cancer-center-research","topic-research","department-biochemistry-and-molecular-biology","department-college-of-pharmacy","department-eppley-institute-for-cancer-research","department-fred-pamela-buffett-cancer-center","department-pediatrics","department-the-child-health-research-institute","department-unmc-front-page","department-unmc-today-todays-headlines","author_override-sarah-hankin-unmc-strategic-communications"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dr. Mahapatra grant to fund medulloblastoma research\u00a0<\/title>\n<meta name=\"description\" content=\"The team led by Sidharth Mahapatra, MD, PhD is exploring a novel treatment against the most lethal form of medulloblastoma.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Mahapatra grant to fund medulloblastoma research\u00a0\" \/>\n<meta property=\"og:description\" content=\"The team led by Sidharth Mahapatra, MD, PhD is exploring a novel treatment against the most lethal form of medulloblastoma.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unmcedu\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T07:58:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-30T19:29:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2025\/02\/SidharthMahapatra021925.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2160\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jeffrey Robb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@unmc\" \/>\n<meta name=\"twitter:site\" content=\"@unmc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jeffrey Robb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/\"},\"author\":{\"name\":\"Jeffrey Robb\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/person\\\/6c55382c243ff55b6c4dee62262b6a5c\"},\"headline\":\"Dr. Mahapatra grant to fund medulloblastoma research\u00a0\",\"datePublished\":\"2025-02-19T07:58:00+00:00\",\"dateModified\":\"2025-09-30T19:29:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/\"},\"wordCount\":677,\"commentCount\":9,\"publisher\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/SidharthMahapatra021925.jpg\",\"keywords\":[\"Cancer Center Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/\",\"name\":\"Dr. Mahapatra grant to fund medulloblastoma research\u00a0\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/SidharthMahapatra021925.jpg\",\"datePublished\":\"2025-02-19T07:58:00+00:00\",\"dateModified\":\"2025-09-30T19:29:37+00:00\",\"description\":\"The team led by Sidharth Mahapatra, MD, PhD is exploring a novel treatment against the most lethal form of medulloblastoma.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/SidharthMahapatra021925.jpg\",\"contentUrl\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/SidharthMahapatra021925.jpg\",\"width\":2160,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2025\\\/02\\\/19\\\/dr-mahapatra-grant-to-fund-medulloblastoma-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Mahapatra grant to fund medulloblastoma research\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#website\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#organization\",\"name\":\"University of Nebraska Medical Center\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/overview-1.png\",\"contentUrl\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/overview-1.png\",\"width\":500,\"height\":153,\"caption\":\"University of Nebraska Medical Center\"},\"image\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/unmcedu\",\"https:\\\/\\\/x.com\\\/unmc\",\"https:\\\/\\\/instagram.com\\\/iamunmc\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UNMCEDU\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/person\\\/6c55382c243ff55b6c4dee62262b6a5c\",\"name\":\"Jeffrey Robb\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/author\\\/d09bf41544a3365a46c9077ebb5e35c3\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Mahapatra grant to fund medulloblastoma research\u00a0","description":"The team led by Sidharth Mahapatra, MD, PhD is exploring a novel treatment against the most lethal form of medulloblastoma.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Mahapatra grant to fund medulloblastoma research\u00a0","og_description":"The team led by Sidharth Mahapatra, MD, PhD is exploring a novel treatment against the most lethal form of medulloblastoma.\u00a0","og_url":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/unmcedu","article_published_time":"2025-02-19T07:58:00+00:00","article_modified_time":"2025-09-30T19:29:37+00:00","og_image":[{"width":2160,"height":1440,"url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2025\/02\/SidharthMahapatra021925.jpg","type":"image\/jpeg"}],"author":"Jeffrey Robb","twitter_card":"summary_large_image","twitter_creator":"@unmc","twitter_site":"@unmc","twitter_misc":{"Written by":"Jeffrey Robb","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#article","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/"},"author":{"name":"Jeffrey Robb","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/6c55382c243ff55b6c4dee62262b6a5c"},"headline":"Dr. Mahapatra grant to fund medulloblastoma research\u00a0","datePublished":"2025-02-19T07:58:00+00:00","dateModified":"2025-09-30T19:29:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/"},"wordCount":677,"commentCount":9,"publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2025\/02\/SidharthMahapatra021925.jpg","keywords":["Cancer Center Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/","url":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/","name":"Dr. Mahapatra grant to fund medulloblastoma research\u00a0","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#primaryimage"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2025\/02\/SidharthMahapatra021925.jpg","datePublished":"2025-02-19T07:58:00+00:00","dateModified":"2025-09-30T19:29:37+00:00","description":"The team led by Sidharth Mahapatra, MD, PhD is exploring a novel treatment against the most lethal form of medulloblastoma.\u00a0","breadcrumb":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#primaryimage","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2025\/02\/SidharthMahapatra021925.jpg","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2025\/02\/SidharthMahapatra021925.jpg","width":2160,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.unmc.edu\/newsroom\/2025\/02\/19\/dr-mahapatra-grant-to-fund-medulloblastoma-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unmc.edu\/newsroom\/"},{"@type":"ListItem","position":2,"name":"Dr. Mahapatra grant to fund medulloblastoma research\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.unmc.edu\/newsroom\/#website","url":"https:\/\/www.unmc.edu\/newsroom\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.unmc.edu\/newsroom\/#organization","name":"University of Nebraska Medical Center","url":"https:\/\/www.unmc.edu\/newsroom\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","width":500,"height":153,"caption":"University of Nebraska Medical Center"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/unmcedu","https:\/\/x.com\/unmc","https:\/\/instagram.com\/iamunmc","https:\/\/www.youtube.com\/user\/UNMCEDU"]},{"@type":"Person","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/6c55382c243ff55b6c4dee62262b6a5c","name":"Jeffrey Robb","url":"https:\/\/www.unmc.edu\/newsroom\/author\/d09bf41544a3365a46c9077ebb5e35c3\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/119499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/users\/75"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/comments?post=119499"}],"version-history":[{"count":2,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/119499\/revisions"}],"predecessor-version":[{"id":119522,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/119499\/revisions\/119522"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media\/119500"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media?parent=119499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/categories?post=119499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/tags?post=119499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}